Magnum Ice Cream reported its first full-year results since its December demerger from Unilever, but posted a disappointing 3% drop in sales volumes in the fourth quarter but is it down to the widespread use of GLP-1 drugs? AJ Bell's Investment Director, Russ Mould joins Bobby to discuss.
Are weight-loss drugs the reason for Magnum ice cream sales slump?
Magnum Ice Cream reported its first full-year results since its December demerger from Unilever,...
10.00 14 Feb 2026
